PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 12 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Essential oil of T. sipyleus subsp. sipyleus var. sipyleus showed antimicrobial activity against associated strains including S. aureus, MRSA, S. epidermidis, S. pyogenes, S. pneumoniae, and P. aeruginosa [PMID:29908309]
Extracts of T. sipyleus subsp. rosulans showed proliferative activities, effects on wound closure, and hydroxyproline synthesis [PMID:31540139]
Methanolic extract showed remarkable amoebicidal activity against trophozoites and cysts [PMID:17661186]
Essential oil of T. sipyleus subsp. sipyleus var. davisianus demonstrated anti-biofilm activity against Gram-positive and Gram-negative bacteria [PMID:25385321]
Essential oils demonstrated antifungal potential against this soil-borne plant pathogen [PMID:41083786]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 38257392 (2024) — Phenolic Content Analysis of Two Species Belonging to the Lamiaceae Family: Antioxidant, Anticholinergic, and Antibacterial Activities. · Molecules (Basel, Switzerland)
- 2.PMID: 38144604 (2021) — Volatile constituents of three Thymus sipyleus Boiss. subspecies from different sites in Turkey. · Turkish journal of chemistry
- 3.PMID: 29908309 (2018) — Anti-inflammatory and antibacterial evaluation of Thymus sipyleus Boiss. subsp. sipyleus var. sipyleus essential oil against rhinosinusitis pathogens. · Microbial pathogenesis
- 4.PMID: 36558163 (2022) — New Biological and Chemical Evidences of Two Lamiaceae Species (Thymbra capitata and Thymus sipyleus subsp. rosulans): In Vitro, In Silico and Ex Vivo Approaches. · Molecules (Basel, Switzerland)
- 5.PMID: 17661186